Business

Africa needs its own Green Revolution

IPN Opinion article

Author: Douglas Southgate

Agricultural technologies that could save millions of lives are being held back from Africans because of the opposition of environmental NGOs and other interest groups.

Hidden costs of Canadian health care system

IPN Opinion article

Author: Brett Skinner

Michael Moore's latest film portrays Canada's healthcare system as a utopian combination of equity and efficiency. The reality is quite the opposite says Brett Skinner of Canada's Fraser Institute.

Economic development in Thailand: In search of the right signals

IPN Opinion article

The Bangkok Post discusses key messages presented during a seminar on property rights, the rule of law and economic development hosted by IPN in Bangkok.

The Real Threat to European R&D

IPN Opinion article

Author: Alec van Gelder

It is governments, who undermine property rights and drive investment and business out of Europe, that are to blame for the falling levels and quality of European R&D, not new competition from the fast-growng countries of Asia.

Thailand violates drug patents for its own profit

IPN Opinion article

Author: Philip Stevens

Thailand claims that its decision to issue compulsory licenses for several western-owned medicines is in the public interest. However, this policy risks increasing already serious resistance to AIDS medicines, with terrible implications for public health.

Net Loss

IPN Opinion article

Author: Alec van Gelder

In spite of its harmless name, "Net neutrality" would damage important innovation and hamper investment into broadband across Europe and possibly elsewhere, warns Alec van Gelder.

The Malaria Donor Score Card

IPN Opinion article

Author: Jasson Urbach

The 25th of April marks Africa Malaria Day when governments, scientists and civil society groups take stock of progress made in fighting the disease and honour lives lost.

Drug-resistant AIDS: The next tsunami

IPN Opinion article

Author: Jeremiah Norris

Although billions were pledged for AIDS at the recent G8 meeting, the neglected issue of drug resistance is now starting to simmer ó and it will soon make current financial commitments seem puny, while damaging the economies of countries already ravaged by HIV/AIDS.